National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
rhIL-11

 A drug used to increase the number of blood cells, especially platelets, in some cancer patients receiving chemotherapy. rhIL-11 is a form of interleukin-11 (a cytokine normally made by support cells in the bone marrow) that is made in the laboratory. It is a type of biological response modifier. Also called Neumega, oprelvekin, and recombinant human interleukin-11.

Previous Definitions:rhabdoid tumor, rhabdomyosarcoma, rheumatism, rheumatoid arthritis, Rheumatrex
Next Definitions:rhinoscope, rhinoscopy, rhizoxin, rhubarb, ribavirin